MOE Key Lab of Bioinformatics, School of Life Sciences, Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing, 100084, China.
Center for Nano and Micro Mechanics, Beijing Key Laboratory of Protein Therapeutics, Center for Synthetic and Systems Biology Tsinghua University, Beijing, 100084, China.
Adv Mater. 2018 Aug;30(31):e1802273. doi: 10.1002/adma.201802273. Epub 2018 Jun 19.
To avoid large open surgery using scaffold transplants, small-sized cell carriers are employed to repair complexly shaped tissue defects. However, most cell carriers show poor cell adherences and viability. Therefore, polyhydroxyalkanoate (PHA), a natural biopolymer, is used to prepare highly open porous microspheres (OPMs) of 300-360 µm in diameter, combining the advantages of microspheres and scaffolds to serve as injectable carriers harboring proliferating stem cells. In addition to the convenient injection to a defected tissue, and in contrast to poor performances of OPMs made of polylactides (PLA OPMs) and traditional less porous hollow microspheres (PHA HMs), PHA OPMs present suitable surface pores of 10-60 µm and interconnected passages with an average size of 8.8 µm, leading to a high in vitro cell adhesion of 93.4%, continuous proliferation for 10 d and improved differentiation of human bone marrow mesenchymal stem cells (hMSCs). PHA OPMs also support stronger osteoblast-regeneration compared with traditional PHA HMs, PLA OPMs, commercial hyaluronic acid hydrogels, and carrier-free hMSCs in an ectopic bone-formation mouse model. PHA OPMs protect cells against stresses during injection, allowing more living cells to proliferate and migrate to damaged tissues. They function like a micro-Noah's Ark to safely transport cells to a defect tissue.
为避免使用支架移植物进行大型开放性手术,采用小尺寸细胞载体来修复形状复杂的组织缺损。然而,大多数细胞载体的细胞黏附性和活力都较差。因此,聚羟基烷酸酯(PHA)作为一种天然生物聚合物,被用来制备直径为 300-360μm 的高度开放多孔微球(OPM),结合了微球和支架的优点,用作具有增殖性干细胞的可注射载体。除了便于注射到受损组织之外,与由聚乳酸(PLA OPM)和传统的较少孔空心微球(PHA HMs)制成的 OPM 相比,PHA OPM 具有合适的 10-60μm 的表面孔和 8.8μm 的平均连通通道,从而实现体外细胞黏附率 93.4%、连续增殖 10 天以及人骨髓间充质干细胞(hMSCs)的分化得到改善。在异位骨形成小鼠模型中,与传统的 PHA HMs、PLA OPMs、商业透明质酸水凝胶和无载体 hMSCs 相比,PHA OPMs 还支持更强的成骨细胞再生。PHA OPM 可在注射过程中保护细胞免受压力,从而使更多的活细胞增殖并迁移到受损组织。它们的作用就像一个微型诺亚方舟,可以安全地将细胞运输到受损组织。